Association of p38MAPK‐p53‐Fas aggregation in S‐allyl cysteine mediated regulation of hepatocarcinoma
S Chatterjee, D Patra, U Chakraborti… - Environmental …, 2019 - Wiley Online Library
Bioactive components of dietary phytochemicals have been reported to possess antitumor
activities. Evidences suggested key role of stress responsive p38MAPK in the induction of …
activities. Evidences suggested key role of stress responsive p38MAPK in the induction of …
α-cyano-4-hydroxycinnamate impairs pancreatic cancer cells by stimulating the p38 signaling pathway
M Schoenrogge, H Kerndl, X Zhang, S Kumstel… - Cellular …, 2018 - Elsevier
Multiple studies are currently targeting dysregulated cancer cell metabolism with distinct
combinations of inhibitors. In this study, we evaluated in pancreatic cancer cells metformin …
combinations of inhibitors. In this study, we evaluated in pancreatic cancer cells metformin …
p38δ mitogen-activated protein kinase regulates skin homeostasis and tumorigenesis
T Efimova - Cell Cycle, 2010 - Taylor & Francis
The p38δ mitogen-activated protein kinase (MAPK) is abundantly expressed in a wide array
of tissues where it is likely to have specific functions. This review aims to highlight recent …
of tissues where it is likely to have specific functions. This review aims to highlight recent …
Dual inhibition of MEK and p38 impairs tumor growth in KRAS‑mutated non‑small cell lung cancer
N Sunaga, Y Miura, Y Tsukagoshi… - Oncology …, 2019 - spandidos-publications.com
Despite the high frequency of KRAS mutations in non‑small cell lung cancer (NSCLC),
therapeutic modalities targeting KRAS‑mutated NSCLC have not been established. Based …
therapeutic modalities targeting KRAS‑mutated NSCLC have not been established. Based …
In silico screening and in vitro activity measurement of javamide analogues as potential p38 MAPK inhibitors
JB Park - International Journal of Molecular Sciences, 2017 - mdpi.com
p38 Mitogen-activated protein kinase (p38 MAPK) is a protein kinase critically involved in
the progress of inflammation/stress-associated diseases. Our data suggested that javamide …
the progress of inflammation/stress-associated diseases. Our data suggested that javamide …
A Review of the Molecular Mechanisms of EGFR and IGFR Receptors in Tamoxifen Resistance in Breast Cancer
S Mansouri, T Samadi, A Teymourzadeh… - Multidisciplinary …, 2022 - mcijournal.com
In breast cancer, overexpression of Estrogen Receptor α-66 (ER-α66) is common and is
observed in nearly 70% of tissues (cancerous breast cancer). This receptor and its …
observed in nearly 70% of tissues (cancerous breast cancer). This receptor and its …
MK2 regulates Ras oncogenesis through stimulating ROS production
Y Kobayashi, X Qi, G Chen - Genes & Cancer, 2012 - journals.sagepub.com
Ras signals through both mitogenic and stress pathways and studies of Ras regulatory
effects of stress pathways hold great promise to control Ras-dependent malignancies. Our …
effects of stress pathways hold great promise to control Ras-dependent malignancies. Our …
An approach to the study of gene expression in hepatocarcinogenesis initiation
BR Olga, S Sokol, V Le-Berre, JM François… - Translational …, 2010 - Elsevier
In carcinogenesis, determination of gene and protein expression profiles is important for
prevention and treatment. Caffeic acid phenethyl ester (CAPE) in a single dose administered …
prevention and treatment. Caffeic acid phenethyl ester (CAPE) in a single dose administered …
Key molecular mechanisms associated with cell malignant transformation in acute myeloid leukemia
NN Orlova, TD Lebedev, PV Spirin, VS Prassolov - Molecular Biology, 2016 - Springer
Cancer, along with cardiovascular disorders, is one of the most important problems of
healthcare. Pathologies of the hematopoietic system are the most prevalent in patients …
healthcare. Pathologies of the hematopoietic system are the most prevalent in patients …
Emerging tools for studying receptor endocytosis and signaling
P Pandita, R Bhalla, A Saini, I Mani - Progress in Molecular Biology and …, 2023 - Elsevier
Ligands, agonists, or antagonists use receptor-mediated endocytosis (RME) to reach their
intracellular targets. After the internalization of ligand-receptor complexes, it traffics through …
intracellular targets. After the internalization of ligand-receptor complexes, it traffics through …